Articles with "subclinical leaflet" as a keyword



Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve Replacement: A Review.

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA cardiology"

DOI: 10.1001/jamacardio.2022.1591

Abstract: Importance Subclinical leaflet thrombosis affects approximately 15% of patients after transcatheter aortic valve replacement (TAVR). The pathophysiology and clinical significance of leaflet thrombosis remain incompletely understood. Defining the optimal management strategy in patients who are… read more here.

Keywords: subclinical leaflet; valve; transcatheter aortic; leaflet thrombosis ... See more keywords

Structural analysis of regional transcatheter aortic valve underexpansion and its implications for subclinical leaflet thrombosis

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal for Numerical Methods in Biomedical Engineering"

DOI: 10.1002/cnm.3641

Abstract: Subclinical leaflet thrombosis has been increasingly recognized following transcatheter aortic valve replacement (TAVR). Determining the risk factors is vital in preventing clinical leaflet thrombosis and ensuring long‐term value durability. Clinical data have indicated that regional… read more here.

Keywords: subclinical leaflet; transcatheter aortic; leaflet thrombosis; leaflet ... See more keywords
Photo from wikipedia

Subclinical Leaflet Thrombosis in Transcatheter and Surgical BioprostheticĀ Valves: PARTNER 3 Cardiac Computed Tomography Substudy.

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of the American College of Cardiology"

DOI: 10.1016/j.jacc.2020.04.043

Abstract: BACKGROUND Subclinical leaflet thrombosis, characterized by hypoattenuated leaflet thickening (HALT) and reduced leaflet motion observed on 4-dimensional computed tomography (CT), may represent a form of bioprosthetic valve dysfunction. OBJECTIVES The U.S. Food and Drug Administration… read more here.

Keywords: subclinical leaflet; year; halt; transcatheter ... See more keywords

Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves

Sign Up to like & get
recommendations!
Published in 2017 at "European Heart Journal"

DOI: 10.1093/eurheartj/ehx369

Abstract: Aims Four-dimensional volume-rendered computed tomography (4DCT) has demonstrated instances of hypo-attenuating leaflet thickening (HALT) with or without hypo-attenuation affecting motion (HAM) after transcatheter and surgical aortic valve implantation (TAVI, SAVR). The temporal pattern of evolution… read more here.

Keywords: aortic valves; subclinical leaflet; halt; bioprosthetic aortic ... See more keywords

Abstract 4142998: Optimizing Transcatheter Aortic Valve Design to Mitigate Subclinical Leaflet Thrombosis

Sign Up to like & get
recommendations!
Published in 2024 at "Circulation"

DOI: 10.1161/circ.150.suppl_1.4142998

Abstract: Introduction: Subclinical leaflet thrombosis is an increasingly recognized complication in patients undergoing transcatheter aortic valve replacement (TAVR). Patients with hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) have a higher incidence of strokes and… read more here.

Keywords: subclinical leaflet; design; geometry; leaflet thrombosis ... See more keywords